About BridgeBio Pharma (BBIO)
BridgeBio Pharma, Inc. is a United States-based company, The Company discovers and develops medicines that target well-characterized genetic diseases. The Company’s product platform divided into three key categories: Mendelian, Oncology and Gene ther... Read more
- USD73.49
- USD76.12
- USD72.73
- USD75.61
- 12.20%
- 354M
- 978.43k
- 2.08M
- 14.5B
- 25.34
- 171.00%
Stock News
3 hours ago
Why Oracle and these 3 unloved software stocks could be the next leg of the AI trade
MarketWatch
4 hours ago
BigPanda Introduces AI-Powered External Observability and a New Partnership with Downdetector by Ookla
Yahoo
4 hours ago
Pfizer’s modest 2026 outlook shows its big investments will take time to pay off
CNBC
5 hours ago
This Google exec became a boss 'overnight' 20 years ago—the most important lesson he's learned as a manager
CNBC